CARDIOVASCULAR DRUGS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
PROPAFENONE HCL: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Propafenone 150mg TabDIN 02243324 | General benefit | $0.6306per source unit | Requirements & sourcesBuild cost plan |
| Apo-Propafenone 300mg TabDIN 02243325 | General benefit | $1.1116per source unit | Requirements & sourcesBuild cost plan |
| Mylan-Propafenone 150mg TabDIN 02457172 | General benefit | $0.6306per source unit | Requirements & sourcesBuild cost plan |
| Mylan-Propafenone 300mg TabDIN 02457164 | General benefit | $1.1116per source unit | Requirements & sourcesBuild cost plan |
| Rythmol 150mg TabDIN 00603708 | General benefit | $0.6306per source unit | Requirements & sourcesBuild cost plan |
| Rythmol 300mg TabDIN 00603716 | General benefit | $1.1116per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:04 Cardiac Drugs.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.
24:12 Vasodilating Drugs.
24:32:08 Angiotensin II Receptor Antagonists.